Eastman Chemical CO Form 4 insider transactions

NYSE
Brian Travis Smith, EVP at Eastman Chemical Co, reports purchasing 1,750 shares of common stock at $68.34 per share.
NYSE
Eastman Chemical Co. Director James J. O'Brien reported a planned acquisition of 1,450 shares of common stock at $68.811 per share, effective August 27, 2025.
NYSE
Eastman Chemical Co. Director Kim Ann Mink purchased 1,450 shares of common stock at $69.3799 per share, increasing her direct beneficial ownership to 2,840 shares.
NYSE
Eastman Chemical Co. Director Julie Fasone Holder acquired 1,453 shares of common stock at $68.80 per share through a pre-arranged trading plan.
NYSE
An Eastman Chemical Co. director acquired 3,000 shares of common stock at $68.6525 per share, signaling confidence in the company.
NYSE
Eastman Chemical Co. Director Brett D. Begemann acquired 1,500 shares of common stock in a pre-planned transaction.
NYSE
Eastman Chemical Director Damon Audia reported a planned purchase of 1,465 shares of common stock at $68.585 per share.
NYSE
Eastman Chemical's SVP, Julie A. McAlindon, has filed a Form 4 indicating a pre-planned purchase of 2,000 shares of common stock.
NYSE
Eastman Chemical's EVP & CCO, Brad A. Lich, purchased 3,280 shares of common stock at $68.49 per share, effective August 27, 2025, under a 10b5-1 plan.
NYSE
Eastman Chemical's EVP and CFO, William Thomas McLain Jr., has filed a Form 4 indicating a planned purchase of 3,670 shares of common stock on August 27, 2025.
NYSE
Eastman Chemical CEO and Board Chair Mark J. Costa acquired 7,400 shares of common stock at $67.89 per share, signaling increased insider confidence.
NYSE
Director Brett D. Begemann acquired 1,575 phantom stock units of Eastman Chemical Co on May 1, 2025, under the Directors' Deferred Compensation Plan.
NYSE
Director Julie Fasone Holder received 1,575 shares of Eastman Chemical Co. restricted stock on May 1, 2025, as part of her annual Restricted Stock Award.
NYSE
Director James J. O'Brien acquired 1,575 shares of Eastman Chemical Co. common stock on May 1, 2025, as part of a restricted stock award.
NYSE
Director Renee J. Hornbaker reports acquisition of 1,575 restricted shares of Eastman Chemical Co. on May 1, 2025, as part of her annual Restricted Stock Award.
NYSE
Director Linnie M. Haynesworth reports acquisition and disposal of phantom stock units and deferral of restricted stock award.
NYSE
Director Kim Ann Mink reports acquisition of 1,575 phantom stock units of Eastman Chemical Co, deferred from a restricted stock award, vesting on May 1, 2026.
NYSE
Director Humberto P. Alfonso acquired 1,575 phantom stock units of Eastman Chemical Co. under the Directors' Deferred Compensation Plan on May 1, 2025.
NYSE
Director Eric L. Butler reports acquisition of 1,575 shares of Eastman Chemical Co. restricted stock as part of annual Restricted Stock Award.
NYSE
Director Donald W. Slager reports acquisition of restricted stock and disposal of common stock in Eastman Chemical Co.
NYSE
Director Donald W. Slager reports changes in beneficial ownership of Eastman Chemical Co. stock due to phantom stock units credited under the Directors' Deferred Compensation Plan.
NYSE
Director Julie Fasone Holder reports the acquisition of 412 phantom stock units in Eastman Chemical Co through the Directors' Deferred Compensation Plan.
NYSE
Director Humberto P. Alfonso reports acquisition of phantom stock units through deferral of director's fees, increasing his holdings in Eastman Chemical Co.
NYSE
Director Kim Ann Mink reported the acquisition of 412 Phantom Stock Units of Eastman Chemical Co on April 7, 2025, through the Directors' Deferred Compensation Plan.
NYSE
Director Brett D. Begemann reports acquisition of phantom stock units through director's deferred compensation plan.
NYSE
Director David W. Raisbeck reports the acquisition of phantom stock units and deferral of retainer fees into Eastman Chemical Co. stock account.
NYSE
Director Linnie M. Haynesworth acquired 412 phantom stock units in Eastman Chemical Co through a directors' deferred compensation plan.
NYSE
Director James J. O'Brien reports acquisition of 412 Phantom Stock Units in Eastman Chemical Co under the Directors' Deferred Compensation Plan.
NYSE
Director Renee J. Hornbaker reports acquiring phantom stock units in Eastman Chemical Co through a directors' deferred compensation plan.
NYSE
Director Eric L. Butler reports acquisition of phantom stock units and deferral of retainer fees into Eastman Chemical Co. stock account.